Halozyme Therapeutics
HALO
#2120
Rank
C$10.17 B
Marketcap
$80.35
Share price
-0.44%
Change (1 day)
50.63%
Change (1 year)

Halozyme Therapeutics (HALO) - Total assets

Total assets on the balance sheet as of June 2024 : C$2.67 B

According to Halozyme Therapeutics's latest financial reports the company's total assets are C$2.67 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Halozyme Therapeutics - Total assets on balance sheet (from 2002 to 2024)

Total assets by year

Year Total assets Change
2023-12-31C$2.29 B-8%
2022-12-31C$2.49 B78.78%
2021-12-31C$1.39 B89%
2020-12-31C$0.73 B0.81%
2019-12-31C$0.73 B22.15%
2018-12-31C$0.60 B-8.13%
2017-12-31C$0.65 B86.01%
2016-12-31C$0.35 B39.21%
2015-12-31C$0.25 B31.14%
2014-12-31C$0.19 B77.76%
2013-12-31C$0.10 B-19.35%
2012-12-31C$0.13 B100.74%
2011-12-31C$66.88 M-26.84%
2010-12-31C$91.43 M12.5%
2009-12-31C$81.27 M-13.12%
2008-12-31C$93.55 M-7.77%
2007-12-31C$0.10 B89.02%
2006-12-31C$53.66 M124.73%
2005-12-31C$23.87 M33.41%
2004-12-31C$17.89 M2009.63%
2003-12-31C$0.84 M132.97%
2002-12-31C$0.36 M774.97%
2001-12-31C$0.04 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
C$0.60 B-77.46%๐Ÿ‡บ๐Ÿ‡ธ USA
C$97.49 B 3,549.49%๐Ÿ‡บ๐Ÿ‡ธ USA
C$35.68 B 1,236.01%๐Ÿ‡บ๐Ÿ‡ธ USA
C$293.24 B 10,877.33%๐Ÿ‡บ๐Ÿ‡ธ USA
C$188.66 B 6,962.63%๐Ÿ‡ซ๐Ÿ‡ท France
C$245.62 B 9,094.85%๐Ÿ‡บ๐Ÿ‡ธ USA